ASCO 2026 — Day-by-Day Summaries ↗
Key presentations from the year's largest oncology congress; clustered by tumor group, with evidence level and a Council note for each.
OncoHub is an agentic AI platform with two products: Compass, an empathetic assistant providing 24/7 support for patients undergoing cancer treatment, and Council, an AI-powered tumor board simulation that strengthens oncologists' clinical decision-making.
Explore the PlatformLeonardo's Vitruvian Man frames the human being holistically: not parts, not proportions, but the whole person. OncoHub was built on this understanding. Cancer is a disease; the patient, even after diagnosis, remains a whole human being.
We use artificial intelligence within this framework. Empathy to ease the patient's emotional burden; depth to ease the physician's clinical burden. Technology is not an end in itself — it is a tool in service of people, and it will remain so.
Explore the Platforms
An empathetic, trustworthy digital companion available 24/7 throughout the cancer treatment journey. Designed for patients and their loved ones.
Without rushing, without creating panic, always guiding you back to your doctor.
Diagnosis, treatment recommendations, and medication dosages are never provided. This is not a limitation — it is a principle.
Protocol information is provided, followed by a "consult your doctor" reminder. Decisions come from the patient and physician.
General process guidance, patient associations, patient rights — information flows freely in this domain.
Immediate referral to emergency care when urgent symptoms are detected. Delay can cost quality of life.

A clinical decision support system that simulates a multidisciplinary tumor board meeting. Designed for oncologists.
Key presentations from the year's largest oncology congress; clustered by tumor group, with evidence level and a Council note for each.
Reimbursement conditions changed by the new policy and how Council reflects these changes.
Sign up now to try Compass for free.
Sign up →Congress files, guideline and reimbursement updates — once a week, to your inbox.
Insurance reimbursement checks, Turkish clinical terminology, local healthcare system integration.
No generation outside the knowledge base; mandatory source citation. Every response is verified.
Validated by an oncology advisory board. Tested against clinical practice.
New cancer types and guideline updates are added without disrupting the existing structure.
Recommendations validated against NCCN, ESMO guidelines and current clinical trials.
Comprehensive data protection policy and privacy standards. Full compliance with Turkish law.

OncoHub's knowledge base is validated by an oncology advisory board. Updates to NCCN and ESMO guidelines are incorporated into the system through its modular architecture without disrupting the existing structure.
Knowledge is not static — it evolves alongside oncology practice.
No. OncoHub Compass never makes diagnoses, recommends treatments, or specifies medication dosages. The platform provides patients with information and emotional support, and offers clinical decision support to physicians. The final decision always rests with your doctor.
Yes. All patient data is processed in compliance with KVKK (Turkish data protection law). Personal information (such as national ID numbers and names) is not stored in the system. Data is not shared with third parties; only registration credentials are stored in encrypted form and can be deleted by the user at any time.
We work with a database providing evidence-based information on more than 50 tumor types. A modular architecture is used, continuously updated on the basis of NCCN, ASCO, and ESMO guidelines.
The Patient Assistant platform has been developed entirely free of charge as a social responsibility initiative. Access to information during cancer treatment is regarded as a right.
OncoHub minimizes hallucination through a four-layer safety architecture. A prohibition on generating content outside the knowledge base, combined with a Chain-of-Verification system, checks every response.
No. This platform has been designed exclusively for specialist healthcare professionals.